# INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and Olodaterol

> **NCT03152149** · PHASE4 · COMPLETED · sponsor: **University of Dundee** · enrollment: 80 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Tiotropium & olodaterol
- **DRUG:** fluticasone furoate & vilanterol

## Key facts

- **NCT ID:** NCT03152149
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2019-11-26
- **Final completion:** 2019-11-26
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-07-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03152149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03152149, "INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and Olodaterol". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03152149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*